311 related articles for article (PubMed ID: 32748745)
1. Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems.
Gencer A; Duraloglu C; Ozbay S; Ciftci TT; Yabanoglu-Ciftci S; Arica B
Curr Drug Deliv; 2021; 18(2):103-120. PubMed ID: 32748745
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment.
Ahmed R; Amreddy N; Babu A; Munshi A; Ramesh R
Methods Mol Biol; 2019; 1974():265-290. PubMed ID: 31099010
[TBL] [Abstract][Full Text] [Related]
3. The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer.
Youngren-Ortiz SR; Chougule MB
Hawaii J Med Public Health; 2017 Nov; 76(11):318-325. PubMed ID: 29164017
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Lamprecht A; Arica B
Int J Pharm; 2024 Jan; 650():123703. PubMed ID: 38092263
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
Babu A; Munshi A; Ramesh R
Drug Dev Ind Pharm; 2017 Sep; 43(9):1391-1401. PubMed ID: 28523942
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
Subhan MA; Torchilin VP
Transl Res; 2019 Dec; 214():62-91. PubMed ID: 31369717
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Targeted Dendrimer Nanoparticles for Combinatorial Delivery of siRNA and Chemotherapy for Cancer Treatment.
Amreddy N; Ahmed RA; Munshi A; Ramesh R
Methods Mol Biol; 2020; 2059():167-189. PubMed ID: 31435921
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy.
Kim YD; Park TE; Singh B; Maharjan S; Choi YJ; Choung PH; Arote RB; Cho CS
Nanomedicine (Lond); 2015; 10(7):1165-88. PubMed ID: 25929572
[TBL] [Abstract][Full Text] [Related]
11. Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells.
Conte C; Monteiro PF; Gurnani P; Stolnik S; Ungaro F; Quaglia F; Clarke P; Grabowska A; Kavallaris M; Alexander C
Nanoscale; 2021 Jul; 13(26):11414-11426. PubMed ID: 34160534
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.
Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S
Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948
[TBL] [Abstract][Full Text] [Related]
13. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
[TBL] [Abstract][Full Text] [Related]
14. Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment.
Amreddy N; Babu A; Panneerselvam J; Srivastava A; Muralidharan R; Chen A; Zhao YD; Munshi A; Ramesh R
Nanomedicine; 2018 Feb; 14(2):373-384. PubMed ID: 29155362
[TBL] [Abstract][Full Text] [Related]
15. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges.
Ezhilarasan D; Lakshmi T; Mallineni SK
Nanomedicine (Lond); 2022 Oct; 17(24):1855-1869. PubMed ID: 35311343
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles containing insoluble drug for cancer therapy.
Guo S; Huang L
Biotechnol Adv; 2014; 32(4):778-88. PubMed ID: 24113214
[TBL] [Abstract][Full Text] [Related]
17. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS; Tekade RK; Chougule MB
J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers.
Yaghmur A; Østergaard J; Mu H
Adv Drug Deliv Rev; 2023 Dec; 203():115136. PubMed ID: 37944644
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers.
Beyaz H; Uludag H; Kavaz D; Rizaner N
Adv Exp Med Biol; 2021; 1347():163-181. PubMed ID: 34287795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
